recall
saveGranules Pharmaceuticals Inc. recall (Cls III)
community read0 votes
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 20 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-032-01 — Reason: Failed Impurities/Degradation Specifications: — Status: Ongoing
view source ↗Data sources
last refreshed 17m ago
Found something off?
same company · ±60 days · 6
- recallGranules Pharmaceuticals Inc. recall (Cls III)Oct 1, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls III)Oct 1, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Oct 1, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls III)Oct 1, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls III)Oct 1, 2025
- approvalENOBY: ENOBY (DENOSUMAB-QBDE) — FDA approvalSep 26, 2025
comments(0)
5-min edit window · permanent after that